Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2002 Oct 21;12(20):2893-7.

Syntheses and EGFR and HER-2 kinase inhibitory activities of 4-anilinoquinoline-3-carbonitriles: analogues of three important 4-anilinoquinazolines currently undergoing clinical evaluation as therapeutic antitumor agents.

Author information

1
Chemical Sciences and Oncology and Immunoinflammatory Research, Wyeth Research, 401N. Middletown Road, Pearl River, NY 10965, USA. wissnea@wyeth.com

Abstract

The syntheses and biological evaluations of 4-anilinoquinoline-3-carbonitrile analogues of the three clinical lead 4-anilinoquinazolines Iressa, Tarceva, and CI-1033 are described. The EGFR and HER-2 kinase inhibitory activities and the cell growth inhibition of the two series are compared with each other and with the clinical lead EKB-569. Similar activities are observed between these two series.

PMID:
12270171
DOI:
10.1016/s0960-894x(02)00598-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center